Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Launched by INTERNATIONAL CONSORTIUM OF CIRCULATORY ASSIST CLINICIANS · Sep 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the HeartMate 3 ® device, which is a type of heart pump used for patients with severe heart failure who may not be able to get a heart transplant. The goal of the study is to gather and analyze data from the pump to understand how it works and how it affects patients’ quality of life, as well as to see how it relates to other health issues that can come up, like infections and strokes. By looking at both normal and abnormal signals from the device, the researchers hope to improve care for patients with this heart pump.

To be eligible for the study, participants need to be at least 18 years old and scheduled to receive a HeartMate 3 ® device. Those under 18 or getting a different kind of heart pump won't be able to take part. Participants can expect to share their experiences and health information while the study looks at how the pump data correlates with their overall health and well-being over time. This research could lead to better understanding and management of patients with heart pumps in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older
• • Scheduled Heartmate 3 ® dLVAD implantation
• Exclusion Criteria:
• • \<18 years of age
• • Scheduled for dLVAD that is NOT a Heartmate 3 (R) device